Pharmaceuticals (14) | Retention Agreements (14)
Browse by Company
Recent Contracts
-
June 21, 2019 Retention Agreement with Douglas Plassche
(ELITE PHARMACEUTICALS INC, Filed With SEC on June 14, 2021)
-
Retention Agreements by and between Tilray and each of Michael Kruteck and Jon Levin dated December 18, 2020
(Tilray, Inc., Filed With SEC on December 21, 2020)
-
Retention agreement, dated October 27, 2020, between Acasti Pharma Inc. and Jan DAlvise
(Acasti Pharma Inc., Filed With SEC on November 16, 2020)
-
Retention agreement, dated October 29, 2020 between Acasti Pharma Inc. and Pierre Lemieux
(Acasti Pharma Inc., Filed With SEC on November 16, 2020)
-
Tricida, Inc. Executive Retention Agreement Template
(Tricida, Inc., Filed With SEC on November 9, 2020)
-
Retention Agreement, dated August 5, 2020, by and between Nabriva Therapeutics US, Inc. and Jennifer Schranz
(Nabriva Therapeutics plc, Filed With SEC on November 5, 2020)
-
EXECUTIVE RETENTION AGREEMENT
(Supernus Pharmaceuticals, Inc., Filed With SEC on October 5, 2020)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Frederick C. Beddingfield III, dated as of September 11, 2019
(Sienna Biopharmaceuticals, Inc., Filed With SEC on November 12, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Alexander Azoy, dated as of September 11, 2019
(Sienna Biopharmaceuticals, Inc., Filed With SEC on November 12, 2019)
-
Management Retention Plan Letter by and between Sienna Biopharmaceuticals, Inc. and Paul Lizzul, dated as of September 11, 2019
(Sienna Biopharmaceuticals, Inc., Filed With SEC on November 12, 2019)
